Satoshi Fukushima Selected Research

Satoshi Fukushima Research Topics

Disease

49	Melanoma (Melanoma, Malignant) 10/2022 - 11/2005
46	Neoplasms (Cancer) 01/2022 - 01/2008
21	Systemic Scleroderma (Systemic Sclerosis) 06/2022 - 02/2012
15	Fibrosis (Cirrhosis) 06/2022 - 02/2012
12	Psoriasis (Pustulosis Palmaris et Plantaris) 03/2022 - 03/2011
10	Autoimmune Diseases (Autoimmune Disease) 05/2020 - 01/2010
8	Extramammary Paget Disease (Paget Disease, Extramammary) 01/2022 - 02/2015
8	Hemangiosarcoma (Angiosarcoma) 10/2021 - 02/2015
8	Neoplasm Metastasis (Metastasis) 07/2021 - 10/2013
8	Dermatomyositis (Dermatopolymyositis) 10/2015 - 09/2011
5	Squamous Cell Carcinoma (Epidermoid Carcinoma) 02/2022 - 02/2014
5	Inflammation (Inflammations) 09/2021 - 02/2012
5	Systemic Lupus Erythematosus (Libman-Sacks Disease) 08/2017 - 10/2012
4	Infections 09/2021 - 05/2011
4	Onychomycosis (Tinea Unguium) 09/2021 - 10/2018
4	Collagen Diseases (Collagen Disease) 05/2020 - 09/2011
4	Myositis (Idiopathic Inflammatory Myopathies) 11/2018 - 10/2012
4	Myasthenia Gravis 11/2018 - 07/2016
3	Disease Progression 08/2022 - 01/2016
3	Pemphigus (Pemphigus Vulgaris) 01/2021 - 04/2013
3	Carcinogenesis 05/2019 - 02/2014
3	Cicatrix (Scar) 08/2017 - 09/2013
3	Ulcer 08/2017 - 09/2013
3	Rheumatic Diseases (Rheumatism) 10/2015 - 07/2012
3	Localized Scleroderma (Morphea) 09/2013 - 01/2013
2	Microsatellite Instability 05/2022 - 02/2022
2	Skin Neoplasms (Skin Cancer) 01/2022 - 07/2017
2	Psoriatic Arthritis 09/2020 - 04/2016
2	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 06/2020 - 01/2019
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2020 - 04/2015
2	Sclerosis 01/2020 - 04/2013
2	Colitis 01/2020 - 01/2019
2	Erythema 01/2020 - 08/2017
2	Hemangioma (Angioma) 09/2018 - 12/2010
2	Rheumatoid Arthritis 05/2018 - 05/2014
2	Atopic Dermatitis (Atopic Eczema) 01/2018 - 03/2011
2	Skin Diseases (Skin Disease) 01/2018 - 08/2014
2	Myocarditis (Carditis) 09/2017 - 07/2016
2	Polymyositis 07/2016 - 10/2012

Drug/Important Bio-Agent (IBA)

20	Proteins (Proteins, Gene)FDA Link 10/2021 - 11/2005
19	MicroRNAs (MicroRNA)IBA 02/2022 - 12/2010
16	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2005
14	CollagenIBA 06/2022 - 02/2012
14	Immune Checkpoint InhibitorsIBA 11/2021 - 01/2016
13	CytokinesIBA 02/2022 - 03/2011
13	NivolumabIBA 05/2021 - 01/2016
12	DNA (Deoxyribonucleic Acid)IBA 03/2022 - 07/2012
10	AntigensIBA 02/2021 - 04/2009
9	AntibodiesIBA 08/2022 - 01/2008
8	Messenger RNA (mRNA)IBA 02/2022 - 12/2010
7	Bleomycin (Blenoxane)FDA LinkGeneric 06/2022 - 04/2013
7	Peptides (Polypeptides)IBA 02/2021 - 11/2008
6	Cell-Free Nucleic AcidsIBA 03/2022 - 09/2020
6	Pharmaceutical PreparationsIBA 01/2022 - 04/2014
5	IpilimumabIBA 03/2021 - 09/2017
5	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020 - 04/2014
5	Tumor Biomarkers (Tumor Markers)IBA 01/2016 - 11/2005
4	LigandsIBA 11/2021 - 01/2016
4	Terbinafine (Lamisil)FDA LinkGeneric 09/2021 - 04/2014
4	EnzymesIBA 07/2017 - 09/2011
3	Small Interfering RNA (siRNA)IBA 06/2022 - 01/2015
3	VaccinesIBA 02/2022 - 04/2009
3	Circulating MicroRNAIBA 01/2022 - 03/2011
3	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 06/2021 - 01/2015
3	Interleukin-17 (Interleukin 17)IBA 02/2021 - 01/2012
3	Collagen Type I (Type I Collagen)IBA 12/2020 - 04/2012
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2020 - 01/2014
3	Docetaxel (Taxotere)FDA Link 01/2020 - 02/2015
3	Silver Sulfadiazine (SSD)FDA LinkGeneric 10/2015 - 09/2013
3	ImmunosorbentsIBA 09/2013 - 09/2011
2	alpha2 Subunit Collagen Type IIBA 06/2022 - 09/2015
2	PromegaIBA 05/2022 - 02/2022
2	Interleukin-23 (Interleukin 23)IBA 01/2022 - 01/2017
2	dabrafenibIBA 12/2021 - 06/2018
2	trametinibIBA 12/2021 - 06/2018
2	efinaconazoleIBA 09/2021 - 10/2018
2	HLA Antigens (Human Leukocyte Antigens)IBA 03/2021 - 01/2016
2	B7-H1 AntigenIBA 03/2021 - 01/2018
2	EpitopesIBA 02/2021 - 11/2008
2	Biological ProductsIBA 12/2020 - 05/2014
2	Transcription Factors (Transcription Factor)IBA 11/2020 - 01/2016
2	cadherin 5IBA 10/2020 - 08/2014
2	AutoantibodiesIBA 08/2020 - 05/2020
2	Bexarotene (LGD1069)FDA Link 06/2020 - 01/2019
2	SolutionsIBA 10/2018 - 01/2018
2	Interleukin-6 (Interleukin 6)IBA 09/2018 - 01/2018
2	Indicators and Reagents (Reagents)IBA 11/2017 - 06/2008
2	Transforming Growth Factors (Transforming Growth Factor)IBA 11/2017 - 01/2013
2	Infliximab (Remicade)FDA Link 05/2016 - 04/2016
2	IntegrinsIBA 09/2015 - 01/2013

Therapy/Procedure

37	Therapeutics 10/2022 - 01/2008
16	Immunotherapy 01/2022 - 04/2009
3	Cell- and Tissue-Based Therapy (Cell Therapy) 05/2021 - 03/2016
3	Combination Drug Therapy (Combination Chemotherapy) 01/2020 - 02/2015
3	Lymph Node Excision (Lymph Node Dissection) 08/2016 - 01/2011
3	Transplantation 11/2011 - 01/2010
2	Injections 08/2022 - 02/2021
2	Radiotherapy 11/2021 - 05/2020
2	Drug Therapy (Chemotherapy) 04/2020 - 02/2015
2	Operative Surgical Procedures 02/2020 - 01/2011